| scholarly article | Q13442814 |
| P356 | DOI | 10.1592/PHCO.29.5.593 |
| P698 | PubMed publication ID | 19397466 |
| P50 | author | Society of Infectious Diseases Pharmacists | Q98732076 |
| P2093 | author name string | Roger White | |
| Robert C Owens | |||
| Conan MacDougall | |||
| Richard H Drew | |||
| Elizabeth D Hermsen | |||
| P2860 | cites work | Demand for prophylaxis after bioterrorism-related anthrax cases, 2001 | Q28397272 |
| Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward | Q30312219 | ||
| Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli | Q30661849 | ||
| Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis | Q33218606 | ||
| Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription | Q33912931 | ||
| Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients | Q34052619 | ||
| Antimicrobial stewardship programs in health care systems | Q34097674 | ||
| Impact of a hospital-based antimicrobial management program on clinical and economic outcomes | Q34299766 | ||
| Maximizing appropriate antibiotic prophylaxis for surgical patients: an update from LDS Hospital, Salt Lake City | Q34326479 | ||
| The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting | Q34509624 | ||
| Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients | Q34560162 | ||
| Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship | Q34591740 | ||
| Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients | Q34742852 | ||
| Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial | Q34806800 | ||
| Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study | Q34999543 | ||
| Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis | Q35030135 | ||
| The impact of antimicrobial resistance on health and economic outcomes | Q35136020 | ||
| A pseudo-outbreak of nosocomial infections associated with the introduction of an antibiotic management programme | Q35541502 | ||
| Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing | Q35561863 | ||
| Antimicrobial stewardship programs as a means to optimize antimicrobial use. Insights from the Society of Infectious Diseases Pharmacists | Q35859951 | ||
| Epidemiological interpretation of antibiotic resistance studies - what are we missing? | Q35954276 | ||
| Controlled trials to improve antibiotic utilization: a systematic review of experience, 1984-2004. | Q36070939 | ||
| The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals | Q36342380 | ||
| Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists | Q36407202 | ||
| Information technology for optimizing the management of infectious diseases | Q36468719 | ||
| Effects of an antibiotic cycling program on antibiotic prescribing practices in an intensive care unit | Q36670642 | ||
| Does antibiotic selection impact patient outcome? | Q36672883 | ||
| Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute | Q36737222 | ||
| Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella | Q39477943 | ||
| Antibiotic optimization. An evaluation of patient safety and economic outcomes | Q41556757 | ||
| Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial | Q41726797 | ||
| Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia | Q43470784 | ||
| Concurrent antibiotic review programs--a role for infectious diseases specialists at small community hospitals | Q43474200 | ||
| Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. | Q43590449 | ||
| Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia | Q43604763 | ||
| The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units | Q43697096 | ||
| Do resident physicians use antibiotics appropriately in treating upper respiratory infections? A survey of 11 programs | Q44086441 | ||
| Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. | Q44220176 | ||
| Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients | Q44223071 | ||
| Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America | Q44275203 | ||
| Evaluation of a computer-assisted antibiotic-dose monitor | Q44507755 | ||
| A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance | Q44510157 | ||
| High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm | Q44573499 | ||
| Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. | Q44702078 | ||
| Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001). | Q44719256 | ||
| Role of infectious diseases consultants in management of antimicrobial use in hospitals | Q44807938 | ||
| Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit | Q44881650 | ||
| Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals | Q44912219 | ||
| Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species | Q45138017 | ||
| Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs | Q46875175 | ||
| Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain | Q48389186 | ||
| Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. | Q50611240 | ||
| A qualitative study of factors influencing antimicrobial prescribing by non-consultant hospital doctors. | Q50745280 | ||
| Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. | Q51643088 | ||
| A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis. | Q51736675 | ||
| Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. | Q52389562 | ||
| Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients. | Q53876940 | ||
| Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia. | Q53924554 | ||
| Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. | Q54174345 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| P304 | page(s) | 593-607 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Pharmacotherapy | Q7180800 |
| P1476 | title | Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America | |
| P478 | volume | 29 |
| Q46172217 | 49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting |
| Q51643101 | Antibiotic stewardship implementation in the EU: the way forward. |
| Q37965696 | Antimicrobial stewardship programs: methods of operation and suggested outcomes |
| Q38073196 | Antimicrobial stewardship: a matter of process or outcome? |
| Q30367226 | Antimicrobial stewardship: philosophy versus practice. |
| Q37890027 | Application of antimicrobial stewardship to optimise management of community acquired pneumonia |
| Q34343376 | Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship |
| Q50481305 | Correlates and Economic and Clinical Outcomes of an Adult IV to PO Antimicrobial Conversion Program at an Academic Medical Center in Midwest United States. |
| Q37460926 | Development of antimicrobial competencies and training for staff hospital pharmacists |
| Q84517852 | Enforcement of antimicrobial policy through restrictions built into system for computerized prescriber order entry |
| Q38176571 | Engaging Pharmacy Students, Residents, and Fellows in Antimicrobial Stewardship |
| Q91940834 | Evaluating carbapenem restriction practices at a private hospital in Manila, Philippines as a strategy for antimicrobial stewardship |
| Q38152936 | Evaluation of new antimicrobials for the hospital formulary. Policies restricting antibiotic use in hospitals |
| Q38060050 | Impact of formulary restriction with prior authorization by an antimicrobial stewardship program |
| Q37993723 | Implementation of a clinical decision support system for antimicrobial stewardship |
| Q44374452 | Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers |
| Q38279726 | Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria |
| Q99570608 | Measuring Antibiotic Stewardship Programmes and Initiatives: An Umbrella Review in Primary Care Medicine and a Systematic Review of Dentistry |
| Q45183500 | Optimizing delivery of care for patients with MRSA infection: focus on transitions of care |
| Q42947354 | Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function |
| Q55312461 | Recognition of Advanced Pharmacy Practice Experience Student Participation Within Antimicrobial Stewardship Activities. |
| Q33721251 | Safer use of antimicrobials in hospitals: the value of antimicrobial usage data |
| Q38282826 | Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting |
| Q35986250 | Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases |
| Q92639009 | Study Protocol on Antimicrobial Stewardship in a Tertiary Respiratory Referral Hospital |
| Q46507964 | The state of antimicrobial stewardship programs in California |
| Q89022489 | Towards a global definition of responsible antibiotic use: results of an international multidisciplinary consensus procedure |
| Q38073195 | Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs |
Search more.